Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Global Macro Monitor
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Global Risk Monitor: Weekly Update – May 2

% of readers think this story is Fact. Add your two cents.


This week, global equities extended their recovery, buoyed by rising optimism over potential U.S.–China trade negotiations. Though no formal talks or trade agreements have been signed and most tariffs remain in place—including broad-based global levies—markets responded positively to U.S. administration signals suggesting some trade deals may be near (recall “Infrastructure Week” during Trump 1.0). This has helped drive the S&P 500 to its ninth consecutive gain, approaching a key technical level at 5747.66, its 200-day moving average.

Investor sentiment has shifted, despite contradictory macroeconomic data. April’s U.S. payrolls report exceeded expectations with 177,000 new jobs, indicating labor market resilience. Meanwhile, Q1 GDP contracted 0.3%, driven primarily by an import surge ahead of expected tariffs. The contraction masked the underlying strength in consumption and business investment, which is probably distorted by the tariffs, pointing to front-loaded demand rather than structural strength.

Dazed and Confused

This divergence is creating confusion among economists. The rally appears disconnected from fundamentals, yet persists amid AI enthusiasm, solid tech earnings x/ Apple, and easing energy prices. Historically, markets revert to hopium and to a bullish default mode. Data from our “S&P500 Significant Digits” table supports this: since 1950, the S&P 500 has posted gains 72.46% of the time on an annual basis, with an average return of 8.71% and a standard deviation of 16.20%.  On a monthly basis, the S&P500 is up 60% of the time.

Market breadth has improved, led by mega-cap tech, small-caps, and renewed strength in the AI sector. However, as noted in multiple reports, the post-tariff economic environment lacks historical analogs, similar to how language models operate without pattern certainty. Without a clear forward path, investors are defaulting to the historical mean—bullish.

Global Markets

Globally, Eurozone Q1 GDP surprised to the upside, but inflation remains sticky. UK sentiment and housing have softened. Japan’s BoJ held rates steady and pushed back policy tightening, citing trade uncertainty. Chinese PMIs deteriorated, yet signals of trade thaw, including selective tariff exemptions, have supported regional equities.

Upshot

In sum, the market rally reflects forward-looking optimism rooted more in narrative than in data. The next test lies at the 5747.66 mark—whether momentum can overcome macro headwinds remains uncertain. The 200-day is just a chip shot away.  Until then, markets appear to be pricing in the best-case scenario, which, in our opinion, will not be the best case as the Administration appears not to know what it wants:  1) Reshoring of manufacturing?  2) The tariff revenue?  Or 3) Lower tariffs for American exports and freer trade?    The macro market is choosing #3, but we believe Trump wants #1; both are mutually exclusive. 

We believe empty shelves are just a few weeks away. 

Stay frosty, folks. 

Markets

  • U.S. equities extended their recovery: S&P 500 posted a ninth consecutive gain, supported by strong earnings and easing trade fears.
  • S&P 500 approaching 5747.66, its 200-day moving average, a key technical resistance level.
  • Market breadth improved, with gains across large-cap tech and small/mid-cap stocks.
  • Investor sentiment is buoyed by optimism over potential U.S.–China trade negotiations, though no agreement has been finalized.

U.S. Market Analysis

  • Strong labor data: April nonfarm payrolls rose by 177,000, exceeding expectations; unemployment steady at 4.2%.
  • Q1 GDP contracted –0.3%, mainly due to a surge in imports ahead of tariff implementation.
  • Markets interpreted the negative GDP print as temporary and driven by front-loaded demand.
  • AI and tech stocks led gains; mega-cap earnings (e.g., Microsoft, Meta) surprised to the upside.
  • Treasury yields rose late in the week, reacting to jobs data; credit markets stable with narrowing spreads.

Global Market Analysis

  • Europe: STOXX 600 +3.44% as trade tension eased; Germany +4.63%, France +3.57%, Italy +4.13%.
  • Eurozone GDP beat expectations in Q1 at +0.4%; inflation remained elevated at 2.2% headline, 2.7% core.
  • Japan: Nikkei +3.15%, TOPIX +2.27%. BoJ held rates steady and downgraded growth and inflation forecasts.
  • Yen weakened modestly; 10Y JGB yield fell to 1.26%.
  • China: Mainland indexes down slightly; Hang Seng +2.38%. Manufacturing PMI fell to 49.0—deepest contraction since Dec. 2023.
  • Beijing hinted at a willingness to resume trade talks with the U.S.; partial tariff exemptions granted on select U.S. goods.

Economics

U.S. Economic Overview

  • Labor market resilient, though early-week data (ADP, JOLTS) showed signs of softening.
  • Consumer spending rose 0.7% in March; PCE inflation flat, offering comfort to the Fed.
  • Market anticipates the Fed will hold rates steady in May; futures pricing of June cut has declined.
  • Surging imports dragged GDP but suggested stronger-than-expected demand fundamentals.

Global Economic Overview

  • Eurozone confidence indicators weakening, pointing to potential softness ahead despite Q1 strength.
  • BoJ cautious amid trade uncertainty; inflation forecasts lowered, rate hike now likely delayed.
  • UK housing cooled; mortgage approvals and business sentiment fell. BoE rate cut expectations rising.
  • EM Asia shows divergence: India progressing in U.S. trade talks; China still assessing path forward.

Week Ahead (May 5–9)

Key U.S. Events:

Economic Data

  • Mon: ISM Services
  • Tue: Trade Balance
  • Wed: FOMC Rate Decision, Consumer Credit
  • Thu: Jobless Claims, Productivity, Unit Labor Costs
  • Fri: No major reports

Earnings Highlights

  • Mon: Palantir, Tyson Foods
  • Tue: AMD, Arista, Marriott, EA
  • Wed: Disney, Uber, Shopify, DoorDash
  • Thu: Coinbase, ConocoPhillips
  • Fri: Enbridge, Sun Life

Key Global Events:

  • Japan CPI: Trade-sensitive inflation indicator due Friday
  • Eurozone PMIs: Key growth/inflation gauge out Wednesday
  • Tariff headlines: Continued trade talks remain the primary wildcard for risk sentiment


Source: https://global-macro-monitor.com/2025/05/03/global-risk-monitor-weekly-update-may-2/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.